Mayflower Healthcare Alliance Ltd 07665222 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is provision of dermatology services Digita Accounts Production Advanced 6.30.9574.0 true 07665222 2024-04-01 2025-03-31 07665222 2025-03-31 07665222 bus:Director2 1 2025-03-31 07665222 bus:OrdinaryShareClass1 2025-03-31 07665222 bus:OrdinaryShareClass2 2025-03-31 07665222 bus:OrdinaryShareClass3 2025-03-31 07665222 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2025-03-31 07665222 core:CurrentFinancialInstruments 2025-03-31 07665222 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 07665222 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 07665222 core:BetweenTwoFiveYears 2025-03-31 07665222 core:WithinOneYear 2025-03-31 07665222 core:FurnitureFittingsToolsEquipment 2025-03-31 07665222 core:MotorVehicles 2025-03-31 07665222 bus:SmallEntities 2024-04-01 2025-03-31 07665222 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 07665222 bus:FilletedAccounts 2024-04-01 2025-03-31 07665222 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07665222 bus:RegisteredOffice 2024-04-01 2025-03-31 07665222 bus:Director1 2024-04-01 2025-03-31 07665222 bus:Director2 2024-04-01 2025-03-31 07665222 bus:Director2 1 2024-04-01 2025-03-31 07665222 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 07665222 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 07665222 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 07665222 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07665222 bus:Agent1 2024-04-01 2025-03-31 07665222 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 07665222 core:MotorCars 2024-04-01 2025-03-31 07665222 core:MotorVehicles 2024-04-01 2025-03-31 07665222 core:OfficeEquipment 2024-04-01 2025-03-31 07665222 core:PlantMachinery 2024-04-01 2025-03-31 07665222 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2024-04-01 2025-03-31 07665222 countries:England 2024-04-01 2025-03-31 07665222 2024-03-31 07665222 bus:Director2 1 2024-03-31 07665222 core:FurnitureFittingsToolsEquipment 2024-03-31 07665222 core:MotorVehicles 2024-03-31 07665222 2023-04-01 2024-03-31 07665222 2024-03-31 07665222 bus:OrdinaryShareClass1 2024-03-31 07665222 bus:OrdinaryShareClass2 2024-03-31 07665222 bus:OrdinaryShareClass3 2024-03-31 07665222 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2024-03-31 07665222 core:CurrentFinancialInstruments 2024-03-31 07665222 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 07665222 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 07665222 core:BetweenTwoFiveYears 2024-03-31 07665222 core:WithinOneYear 2024-03-31 07665222 core:FurnitureFittingsToolsEquipment 2024-03-31 07665222 core:MotorVehicles 2024-03-31 07665222 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 07665222 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 07665222 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07665222

Mayflower Healthcare Alliance Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Mayflower Healthcare Alliance Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 10

 

Mayflower Healthcare Alliance Ltd

Company Information

Directors

Mr David John Smith

Dr Usman Bello Buhari

Registered office

Heybridge House
Southend Road
Billericay
Essex
CM11 2PL

Accountants

SJB & Co
Chartered Accountants8 Barnfield
Feering
Colchester
Essex
CO5 9HP

 

Mayflower Healthcare Alliance Ltd

(Registration number: 07665222)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

14,656

47,823

Current assets

 

Stocks

5

52,145

25,000

Debtors

6

489,541

778,560

Cash at bank and in hand

 

802,751

389,337

 

1,344,437

1,192,897

Creditors: Amounts falling due within one year

7

(1,358,401)

(1,187,754)

Net current (liabilities)/assets

 

(13,964)

5,143

Total assets less current liabilities

 

692

52,966

Creditors: Amounts falling due after more than one year

7

-

(21,177)

Net assets

 

692

31,789

Capital and reserves

 

Called up share capital

8

200

200

Retained earnings

492

31,589

Shareholders' funds

 

692

31,789

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 December 2025 and signed on its behalf by:
 

 

Mayflower Healthcare Alliance Ltd

(Registration number: 07665222)
Balance Sheet as at 31 March 2025

.........................................
Mr David John Smith
Director

.........................................
Dr Usman Bello Buhari
Director

 

Mayflower Healthcare Alliance Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Heybridge House
Southend Road
Billericay
Essex
CM11 2PL
England

These financial statements were authorised for issue by the Board on 30 December 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Mayflower Healthcare Alliance Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

Straight line 3-5 years

motor cars

Straight line 5 years

Other tangible assets

Straight line 2 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

Mayflower Healthcare Alliance Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 39 (2024 - 30).

 

Mayflower Healthcare Alliance Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 April 2024

218,043

83,789

301,832

Additions

7,826

-

7,826

Disposals

-

(41,139)

(41,139)

At 31 March 2025

225,869

42,650

268,519

Depreciation

At 1 April 2024

194,903

59,106

254,009

Charge for the year

16,310

8,228

24,538

Eliminated on disposal

-

(24,684)

(24,684)

At 31 March 2025

211,213

42,650

253,863

Carrying amount

At 31 March 2025

14,656

-

14,656

At 31 March 2024

23,140

24,683

47,823

5

Stocks

2025
£

2024
£

Other inventories

52,145

25,000

6

Debtors

Current

Note

2025
£

2024
£

Trade debtors

 

204,013

144,435

Amounts owed by related parties

12

263,707

263,707

Prepayments

 

11,293

-

Other debtors

 

10,528

370,418

   

489,541

778,560

7

Creditors

Creditors: amounts falling due within one year

 

Mayflower Healthcare Alliance Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

9

-

3,962

Trade creditors

 

1,216,666

1,012,134

Taxation and social security

 

59,697

81,223

Accruals and deferred income

 

63,790

76,500

Other creditors

 

18,248

13,935

 

1,358,401

1,187,754

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

9

-

21,177

8

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

A Ordinary shares of £1 each

100

100

100

100

B Ordinary shares of £1 each

50

50

50

50

C Ordinary shares of £1 each

50

50

50

50

200

200

200

200

9

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Hire purchase contracts

-

21,177

2025
£

2024
£

Current loans and borrowings

HP and finance lease liabilities

-

3,962

10

Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

 

Mayflower Healthcare Alliance Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

2025
£

2024
£

Not later than one year

18,658

12,466

Later than one year and not later than five years

26,795

3,134

45,453

15,600

The amount of non-cancellable operating lease payments recognised as an expense during the year was £28,081 (2024 - £19,731).

11

Dividends

Interim dividends paid

2025
£

2024
£

Interim dividend of £200.00 (2024 - £1,240.00) per each A Ordinary shares

20,000

124,000

Interim dividend of £600.00 per each B Ordinary shares

30,000

30,000

Interim dividend of £700.00 per each C Ordinary shares

35,000

35,000

85,000

189,000

12

Related party transactions

Transactions with directors

2025

At 1 April 2024
£

Advances to director
£

Repayments by director
£

At 31 March 2025
£

Dr Usman Bello Buhari

Loan account on interest free terms, repaid within 9 months of the year-end

(3,488)

10,000

(312)

6,200

Dividends paid to directors

2025
£

2024
£

Mr David John Smith

A shares Interim Dividends

10,000

62,000

 

 

Dr Usman Bello Buhari

A Shares Interim Dividend

10,000

62,000

 

 

Summary of transactions with entities with joint control or significant interest

 

Mayflower Healthcare Alliance Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

The company has made loans to Integrated Dermatology Solutions Ltd and Integrated Clinical Solutions Ltd, companies owned and controlled by the directors The loans made in the year to Integrated Dermatology Solutions Ltd totalled £130,982 (2024: £130,182 ) and to Integrated Clinical Solutions Ltd £132,724 (2024: £132,724).
The loans are on interest free terms and have no fixed repayment terms.